Publication

Determinants of HIV-1 broadly neutralizing antibody induction

Related publications (32)

About
Privacy
Disclaimer

Graph Chatbot

Chat with Graph Search

Ask any question about EPFL courses, lectures, exercises, research, news, etc. or try the example questions below.

DISCLAIMER: The Graph Chatbot is not programmed to provide explicit or categorical answers to your questions. Rather, it transforms your questions into API requests that are distributed across the various IT services officially administered by EPFL. Its purpose is solely to collect and recommend relevant references to content that you can explore to help you answer your questions.

Determinants of HIV-1 broadly neutralizing antibody induction

Graph Chatbot

Chat with Graph Search

Peptide-based virucidal drugs

Poloxamers Have Vaccine-Adjuvant Properties by Increasing Dissemination of Particulate Antigen at Distant Lymph Nodes

Induction of a strong and long-lasting neutralizing immune response by dPreS1-TLR2 agonist nanovaccine against hepatitis B virus

The interplay between human genetic variation, chronic inflammation and persistent infection: relevance for cardiovascular morbidity

A Nanoscaffolded Spike-RBD Vaccine Provides Protection against SARS-CoV-2 with Minimal Anti-Scaffold Response

A high-throughput cell- and virus-free assay shows reduced neutralization of SARS-CoV-2 variants by COVID-19 convalescent plasma

On the exploration of novel methodological approaches for immunogen design: case studies in influenza and hepatitis C

Rationally designed Human Cytomegalovirus gB nanoparticle vaccine with improved immunogenicity

Atomic-Scale Description of Interfaces between Antigen and Aluminum-Based Adjuvants Used in Vaccines by Dynamic Nuclear Polarization (DNP) Enhanced NMR Spectroscopy

Functional de novo Protein Design for Targeted Vaccines and Synthetic Biology Applications